AI Optics: "Demand Exceeded Available Supply" as the Growth Curve Re-Accelerates — Quick Take
Lumentum was the #2 name by turnover on the Sat 10 Oct US VolumeSurge (+5.22% to $1,103.35 on 5.2M shares / $5.8B turnover, Technology) — and, with the two larger/adjacent picks already covered (MRNA on 25 Sep, inside the 30-day window; HUM yesterday on 10 Oct), it was the largest uncovered large-cap on the screen. The dominant Healthcare cluster (22/50 names) has no remaining ≥$15B name that hasn't been covered in the last 30 days, so the tape's biggest live AI-infrastructure signal — in the #2 sector (Technology, 14/50) — is the actionable one. The HK VolumeSurge of Fri 9 Oct passed just 2/2,817 (1787.HK $537M and 0256.HK $1M turnover, both far below the $15B floor), so no HK signal applied.
The company-specific catalyst is an AI-optics demand signal, not an earnings date: CEO Michael Hurlston has said publicly that demand for Lumentum's optical components has exceeded available supply, and the sell-side has been repricing into it — a price target raised to $1,232 from $1,100, a fresh Bernstein initiation at Outperform, $1,220, and Northland flagging "a raft of positive data points" from key customers (Lumentum, Ciena) feeding the optical supply chain. It lands squarely on the dominant theme of the 10 Oct news summary — AI as plumbing, not price ("Nvidia GPUs are everywhere. Here are the ways companies are accessing them"). First-time coverage; no re-research callout.
| Year | Revenue | Rev Growth | Op Margin | Net Income (GAAP) |
|---|---|---|---|---|
| FY2022 (Jul '22) | $1,713M | -1.7% | 18.1% | $198.9M |
| FY2023 (Jul '23) | $1,767M | +3.2% | -2.3% | -$131.6M |
| FY2024 (Jun '24) | $1,359M | -23.1% | -26.6% | -$546.5M |
| FY2025 (Jun '25) | $1,645M | +21.0% | -11.7% | $25.9M |
| FY2026 (Jun '26) | $3,014M | +83.2% | 17.8% | -$6,935M* |
*The FY2026 GAAP net loss is not an operating result: it reflects a one-time, non-cash $7.8B loss on debt extinguishment from equitizing convertible notes in Q4. On a non-GAAP basis, FY2026 net income was $782.3M ($8.67/sh) vs $146.4M ($2.06/sh) in FY2025, and Q4 non-GAAP net income was $326.3M ($3.23/sh) vs $63.3M ($0.88/sh) a year earlier. Q4 FY2026 revenue was $1,006M, +109.3% YoY, with non-GAAP gross margin above 50% and non-GAAP operating margin of 36.6% (+2,150bps YoY). Q1 FY2027 guidance: revenue $1.225–1.275B, non-GAAP operating margin 39.5–40.5%, non-GAAP diluted EPS $4.05–4.35 — reaching the target model a quarter early. Balance sheet: $2.7B cash and short-term investments vs $1.67B total debt → net cash ~$1.07B (from net debt ~$1.73B a year ago); TTM FCF $300M. Segment mix: components $2,006M / systems $1,008M.
This is the cleanest pure-play on the AI-optics bottleneck — a real revenue-and-margin inflection (FY26 revenue +83%, op margins through 40% guided) dressed in a genuinely extreme valuation, where the GAAP numbers are polluted by a $7.8B non-cash note equitization. The edge is that the optical-interconnect TAM is still expanding into in-rack connectivity and demand is running ahead of supply; the risk is that you are paying ~51x forward and ~33x sales for a hardware cycle that can be paused by a single hyperscaler budget review, with consensus targets barely above spot. Interesting to watch and own on a pullback, not to chase here at $1,103.
Disclaimer: AI-generated quick take for informational purposes only. Not investment advice. Data from public filings and financial data providers. Market data as of the 9 Oct 2026 close ($1,103.36).